Abstract
Intrauterine viral infections during pregnancy by pathogens such as Zika virus, Cytomegalovirus, Rubella and Herpes Simplex virus can lead to prenatal as well as postnatal neurodevelopmental disorders. Although maternal viral infections are common during pregnancy, viruses rarely penetrate the trophoblast. When they do cross, viruses can cause adverse congenital health conditions for the fetus. In this context, maternal inflammatory responses to these neurotropic pathogens play a significant role in negatively affecting neurodevelopment. For instance, intrauterine inflammation poses an increased risk of neurodevelopmental disorders such as microcephaly, schizophrenia, autism spectrum disorder, cerebral palsy and epilepsy. Severe inflammatory responses have been linked to stillbirths, preterm births, abortions and microcephaly. In this review, we discuss the mechanistic basis of how immune system shapes the landscape of the brain and how different neurotropic viral pathogens evoke inflammatory responses. Finally, we list the consequences of neuroinflammation on fetal brain development and discuss directions for future research and intervention strategies.
Introduction
Neurodevelopment is a complex developmental process that begins during the third week of gestation and continues postnatally until adulthood (Stiles and Jernigan, 2010). In the fetal brain, about 86 billion neurons must be generated in a spatiotemporally coordinated manner, with any deviations resulting in developmental defects and cognitive impairments (Azevedo et al., 2009; Herculano-Houzel, 2009; Kang et al., 2011). The formation of neuroectoderm, which gives rise to the neural tube, is the first step in brain development. Following that, forebrain, midbrain, and hindbrain are generated in a controlled and systematic manner, developing into a functional brain (Chan et al., 2017; Elshazzly and Caban, 2019). Symmetric division of neuroepithelial cells (stem cells) that line the ventricles of the neuroectoderm results in the generation of additional neural stem cells, whereas asymmetrical division gives rise to radial glia and later differentiated cells such as neurons and various glial cells (Götz and Huttner, 2005; Subramanian et al., 2017). Newly formed neurons migrate to the cortical plate and populate distinct layers, culminating in the six-layered neocortex, which accounts for the vast majority of brain volume (Nadarajah and Parnavelas, 2002; Ayala et al., 2007). Therefore, the balance between symmetric and asymmetric cell divisions is critical in determining the brain volume and cognitive capacity (Lu et al., 2000; Huttner and Kosodo, 2005; Knoblich, 2008; Lazutkin et al., 2019). After neurons complete their migration, their projections- axons and dendrites- form synapses with appropriate synaptic partners. The earliest synaptic connections thus formed in the preplate, as early as week 5, aid in the establishment of neuronal connections from thalamus and brainstem. These early synapses contribute to the formation of more stable connections later in development (Tau and Peterson, 2010). Genetic defects, environmental perturbations or pathogens can promote mitotic defects in progenitor cells or apoptosis resulting in hypocellularity leading to disruption of the stem cell balance, which often manifests as neurodevelopmental disorders such as microcephaly and lissencephaly (Chavali et al., 2014; Heffernan and Hare, 2018). In contrast to these catastrophic failures of cell death and fate specification, changes in the neural circuit formation and functions can result in other neurodevelopmental disorders such as autism spectrum disorders (ASD) and schizophrenia.
Proliferation and programmed cell death are both vital in sculpting the landscape of a developing brain. Programmed cell death is required for (i) neural tube closure and neuroepithelial modeling (Yamaguchi et al., 2011) and (ii) to reduce replication errors by terminating cells with unfavorable genomic changes (Rehen et al., 2001; Peterson et al., 2012; Bushman and Chun, 2013). Furthermore, programmed cell death also regulates neuronal identity and patterning by eradicating population of neurons with improper projections, which might affect axonal targeting (Clarke et al., 1998; Yamaguchi and Miura, 2015). Failure to do so and eliminate surplus neurons can result in detrimental neurodevelopmental consequences (Kanold, 2009). For instance, individuals with ASD have an enlarged brain phenotype (macrocephaly) in their early years, characterized by an aberrant expansion of neocortical excitatory neurons, skewing the balance between excitatory and inhibitory circuits (Courchesne et al., 2011; Fang et al., 2014; Wei et al., 2014). On the other hand, uncontrolled apoptosis of progenitors can cause microcephaly or schizophrenia, which is characterized by localized non-lethal apoptosis, that can cause neurite and synaptic loss (Oppenheim, 1991; Chambers et al., 2004; Jarskog et al., 2005).
In this regard, the role of immune system in brain development is paramount (Zengeler and Lukens, 2021). In the sections that follow, we provide insights into how the proper functioning of the immune system is critical for brain development, and how prolonged inflammation caused by the maternal immune system in response to viral infections might jeopardize fetal neurodevelopment.
Immune System of the Developing Brain
The central nervous system (CNS) and the immune system are complex organ systems which are intricately linked. Indeed, there is an evolutionary correlation in the emergence of acquired immunity and the highly developed myelin sheath in neurons (Stassart et al., 2018). The immune system of the brain comprises physical barriers such as blood-brain barrier (BBB), blood-CSF barrier (perivascular BCSFB) and an innate immune system composed of specialized non-neuronal cells known as microglia (Fenstermacher, 1980; Ballabh et al., 2004; Daneman and Prat, 2015) (Figure 1). Furthermore, in response to environmental insults, immune cells from the periphery can infiltrate via the lymphatic drainage portal (glial-lymphatic pathway) (Iliff et al., 2012). The presence of various physical barriers such as BBB and BCSFB indicates an evolutionarily conserved strategy for brain protection. The BBB forms as early as gestational week 8, beginning with telencephalon vascularization and progressing through coordinated cell-cell communications between CNS and the neurovascular unit during the subsequent stages (Saunders et al., 2012). The adult BBB is made up of endothelial cells, pericytes, astrocytes, microglia, and neurons. The embryonic BBB, on the other hand, lacks neurons and astrocytes but is nonetheless functional (Pardridge, 2005; Abbott et al., 2010; Daneman and Prat, 2015). The influx transporters of the BBB transport glucose, minerals, vitamins, hormones and other essential substances, through diffusion, receptor mediated transcytosis or solute carrier transporters to meet the nutrient needs of the developing brain (Roberts et al., 2008). Thus, infections or other neurotoxins breaking the BBB during pregnancy would have a detrimental impact on fetal neurodevelopment. The principal purpose of BCSFB, which is made up of cuboidal epithelium from the choroid plexus, is to secrete cerebrospinal fluid (CSF) into the brain ventricles, where it bathes neurogenic niches in nutrients (Saunders et al., 2012; Liddelow, 2015).
FIGURE 1
In addition to these barriers, the innate immune cells of brain play a significant role in neurodevelopment. The various roles of the brain’s major innate immune cells, namely microglia, in neurodevelopment are well established. Microglia are brain tissue resident macrophages that arise from hematopoietic progenitors and populate the developing brain before BBB formation (Nayak et al., 2014; Colonna and Butovsky, 2017). Microglia provide tropic support to the other major cells of brain such as astrocytes and neurons and facilitate response to signals received from the surrounding neural environment (Nayak et al., 2014; Prinz et al., 2019) (Figure 2). For example, microglia maintain the homeostasis of a healthy brain by synaptic pruning, by constant monitoring of synaptic function which allows for maturation or elimination based on special complement and/or chemokine receptors found exclusively in microglia (Harrison et al., 1998; Paolicelli et al., 2011). Upon activation of the complement cascade, the effector complement C3 tags the appropriate synapse. Microglia express specific C3 receptors (C3R) which bind to the C3 fragment and phagocytose the synapse, resulting in pruning (Figure 2) (Stevens et al., 2007; Magdalon et al., 2020). Furthermore, microglia promotes (i) angiogenesis and vascularization by clearing excess vessels (Dudiki et al., 2020), (ii) proliferation and migration of neurons and glia (Aarum et al., 2003), (iii) programmed cell death of neural stem cells and neurons (Sierra et al., 2010), (iv) myelination (Traiffort et al., 2020), (v) establishment of neuronal circuits (Miyamoto et al., 2016), and (vi) the abundance of neural stem cells (Cunningham et al., 2013).
FIGURE 2
Primary adaptive immune cells (T and B cells) are less common in the brain parenchyma than microglia and are mostly found in the choroid plexus and meninges. T cells, despite their small number, play an important role in spatial learning, memory, and stress response (Kipnis, 2016; Korn and Kallies, 2017). Interestingly, Morris-water-maze test on mice showed that a distinct population of antigen positive CD4+ T cells specifically at the meninges promote learning and memory (Radjavi et al., 2014). While B cells might not be required for these functions, they do accumulate in the neonatal brain and decline with age (Tanabe and Yamashita, 2018). B cells (B1a) promote the proliferation of Oligodendrocyte precursor cell via IgM-Fcα-μR signaling and contribute to oligodendrogenesis (Tanabe and Yamashita, 2018). Thus immune cells not only defend against invading microbes and fight infection, but they also contribute to the brain development through the secretion of unique molecules known as cytokines.
Cytokines in Normal Neurodevelopment
What is the source of cytokines in the fetal brain? Basal cytokine production begins in the fetal brain as early as the fifth week of gestation and is critical for normal neurodevelopment (Mousa et al., 1999; Deverman and Patterson, 2009). These cytokines are primarily secreted by microglia and astrocytes, while the role of neurons in inflammatory response is becoming more evident (Freidin et al., 1992; Hanisch, 2002; Galic et al., 2012; Stolp, 2013). Additionally, maternal cytokines can enter the fetal brain from periphery and/or via the placenta. Maternal cytokines can enter the brain by (i) passive diffusion bypassing the BBB where they bind to endothelial cells and induce secondary messenger signaling, (ii) endocytosis or (iii) by direct secretion at the nerve terminals (Watkins et al., 1995). Based on their role during immune response, the secreted cytokines can be broadly classified as pro- or anti-inflammatory cytokines. The major anti-inflammatory cytokines viz., IL4, IL10, IL1RA, IL11 and IL13, belong to the Interleukin (IL) family. Among the most important pro-inflammatory cytokines are the tumor necrosis factor α (TNFα), interferon γ (IFNγ), IL1 and IL18. However, cytokines can be pro- or anti-inflammatory depending on the context, as exemplified by IL6 and transforming growth factor beta (TGFβ) (Sanjabi et al., 2009; Tanaka et al., 2014). TGFβ is an important mediator of oligodendrocyte differentiation and polarizes microglia to sites of injury near pericytes (O’Keefe et al., 1999). The role of pro-inflammatory cytokines in normal neurodevelopment has come to the forefront particularly with the revelation that enhancement in the levels TNFα and IL1β coincide with major neurodevelopmental events and their roles in neuronal connectivity (Garay and McAllister, 2010; Ratnayake et al., 2013). Additionally, IFNγ in combination with TNFβ and IL1 induces the expression of the major histocompatibility complex 1 (MHC1), which is a glycoprotein expressed by all nucleated cells in the body (Raval et al., 1998). MHCs are broadly classified into two classes: Class I (ubiquitously expressed) and Class II (Antigen presenting cells). Activated MHC1 negatively regulates axon outgrowth, dendritic branching and synaptic density particularly in the hippocampal region of the brain, which is required for learning and memory (Cebrián et al., 2014). As seen with schizophrenia, any condition that triggers maternal MHC1 signaling has the potential to downregulate neuronal synapses and connectivity (Gaser et al., 2004).
Accumulating evidence suggests that a special class of cytokines called chemokines, initially thought only to attract immune cells to the site of inflammation, play a variety of roles in CNS development and in adult brain functioning (Miller et al., 2008; Trettel et al., 2020). For example, chemokine CXCR4 which evolved prior to the emergence of immune system has an important role in neural stem cell migration during injuries. CXCL12-CXCR4 influence the migration of neuronal precursors, axon guidance/pathfinding and maintenance of neural progenitor cells (NPCs) (Dziembowska et al., 2005; Li and Ransohoff, 2008). Chemokine signaling via CX3CL1 and CX3CR1 is neuroprotective and mediates communication between neurons and microglia, thus affecting synaptic pruning (Biber et al., 2007; Pawelec et al., 2020).
The balance between different cytokines in immune system also helps to preserve the barrier integrity. Interferons (Type1), such as IFNβ and IFNα that signal through IFNαR, are produced in response to pathogen-associated molecular patterns (PAMPs)(Zanin et al., 2021). These IFNs promote tight junction formation and preserve its integrity via the cytoskeletal GTPase Rac1, that promotes endothelial barrier function (Al-Sadi et al., 2009; Meunier and Broz, 2016). In contrast, IFNγ–CXCL10 signaling enhances BBB permeability due to internalization and downregulation of tight junction proteins (Daniels and Klein, 2015). Therefore, external stimuli such as viral infections that elicit different maternal cytokine secretion could have a long-standing consequence on the fetal neurodevelopment.
Maternal Infections and Neurodevelopment
How do different viruses trigger immune response and reprogram neurodevelopment? The link between maternal infection status and fetal brain development garnered attention in late 1960s and early 1970s, when an increased infant mortality and/or high incidences of neurosensory deficiencies in newborns during the rubella epidemic was reported (Stern et al., 1969; Chess, 1971; Hutton, 2016). Children born during the rubella epidemic had delayed development and cognitive impairment. Similarly, maternal influenza infection has been linked to an increased risk of schizophrenia in adult life (Mednick et al., 1988; Kendell and Kemp, 1989). Subsequently, a number of clinical epidemiological studies revealed that a plethora of viral infections in pregnant mothers can result in neurological abnormalities ranging from encephalitis in the developing fetus to neuroprogressive and neurodegenerative diseases postnatally (Scola and Duong, 2017; Table 1).
TABLE 1
| Virus | Host Cell entry receptor | Major CNS cells affected | Cytokine signature post infection | Neurological consequences |
| Cytomegalovirus (CMV) | Platelet-Derived growth factor, Neuropilin2, Olfactory receptor 14I1, Epidermal growth factor receptor (EGFR), Tetherin | Neurons, Glia, Ependymal cells, Choroid plexus | Monocyte chemoattractant protein 1 (MCP1) IL8, TNFα, IL6, CXCL11/ITAC, and CCL5/Regulated on Activation, Normal T Expressed and Secreted (RANTES), IL1B, IL10 | Neurosensory loss, Focal encephalitis, Microcephaly, Seizures, Paralysis, Mental retardation, Autism spectrum disorder |
| Herpes Simplex Virus 1 (HSV-1) | Myelin-associated glycoprotein (MAG), Sialic- acid-binding Ig-like lectin, Non-muscle myosin heavy chain (NMHC)-IIA, Nectin 1 | Hippocampal neurons, Brain stem neurons | Macrophage inflammatory protein1a (MIP1a), IL1β, TNFα, IL6, IL8, CCL5, CXCL10 | Necrotizing encephalitis, Multiple sclerosis, Alzheimer’s disease |
| Epstein-Barr virus (EBV) | CD21, CD35 | Astrocytes and Microglia | IL2, IFNγ, TNF, LTα, LTβ, CXCL10-CXCR3, CCL5-CCR5 | Encephalitis, Meningitis, Cerebellitis, Polyradiculomyelitis, Transverse myelitis, Cranial and Peripheral neuropathies, Schizophrenia, Psychiatric abnormalities |
| Varicella-zoster virus | Mannose-6-phosphate receptor, Myelin associated glycoprotein (MAG) | Neurons | IL1, IL6, IL8, and Tumor necrosis factor alpha (TNFα) | Aseptic meningitis, Encephalitis, Cerebral infarction associated with granulomatous vasculitis, Myelitis, and Cranial polyneuropathy. |
| Rubella virus | Myelin oligodendrocyte glycoprotein (MOG), Signaling lymphocytic activation molecule (SLAMF1), CD46 | Astrocytes, Neural progenitor cells | IL1β, IL6, TNFα | Congenital Rubella syndrome, Microcephaly, Encephalitis, Panencephalitis, Autism spectrum disorder |
| Mumps virus | Trisaccharide containing -2,3-linked sialic acid | Ependymal cells that line the ventricles, pyramidal cells in the cerebral cortex and hippocampus | TNFα, IL6, MCP1, CXCL10 | Encephalitis, Aseptic meningitis |
| Influenza virus | Sialic acids (SAs) of cell surface glycoproteins and glycolipids | Hippocampal neurons in the CA1 and dentate gyrus | IL8, RANTES, MCP1, MCP3, MIP1α, IFNG induced protein 10 (IP-10) IL8, IL1B, IL6, IL18, TNFα and IFN α/ß | Neural tube defects, Hydrocephaly, Schizophrenia, Autism spectrum disorder |
| Human Immunodeficiency Virus 1 (HIV1) | CD4, CCR5, CXCR4 | Microglia | TNFα, IFNα, IL6, IL8, IL1β, CCL2 and CCL5 | Microcephaly, Slow neurodevelopment, Dementia, Increased risk of schizophrenia |
| Polio virus | Human poliovirus receptor (PVR) or CD155 | Motor neuron cells in CNS | IL6, IL8, CXCL10, IFNß | Paralytic poliomyelitis |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) | Angiotensin-converting enzyme 2 (hACE2), Transmembrane protease serine 2 (TMPRSS2) | Choroid plexus cells, neurons | IL17, IL1, IL6, TNFα, IL15, IFNγ | Neurodevelopmental disorders? |
| Japanese Ecephalitis Virus (JEV) | Plasmalemma Vesicle Associated Protein (PLVAP), Gastrokine-3 precursor (Gkn3), C-Type Lectin Domain Containing 5A (CLEC5A), Heparansulfate, Glucose regulatory protein 78 (GRP78), Scavenger receptor I | Pyramidal neurons of the cerebrum, Purkinje cells of the cerebellum | IFNα, IL8, RANTES, IL6 | Encephalitis, Paralysis, Seizures, Inability to speak, Memory loss, Impaired cognition, and other Mental disorders |
| Zika virus (ZKV) | TAM (AXL), Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin (DC SIGN), Neural cell adhesion molecule 1 (NCAM1), Tyro 3 | Neural Stem Cell (NSC), Neural Progenitor Cell (NPC) | Il1Rα, IL2, IL9, IL15, IFNγ, CXCL10, CXCL9 | Microcephaly, Autism spectrum disorder |
| West Nile Virus (WNV) | TLR3, C type lectins, T cell Ig- and mucin domain–containing, molecule (TIM), and Tyro3, Axl, and Mertk (TAM), Natural Killer p44 (NKP44) | Neurons, Bovine microvascular endothelial (BMVE), Astrocytes, Microglia, Endothelial cell (EC) | IL1β, IL2, TNFα | Encephalitis, Depression, Memory loss and Motor dysfunction |
| Dengue Virus (DENV) | C-type lectin domain containing 5A (CLEC5A), TIM and TAM, Heparan sulfate, GRP78, Scavenger receptor I, Integrin αvβ3, Claudin 1, Nkp44, Laminin | Neurons, Astrocytes | IL8, IL13, MCP3, Granulocyte-macrophage colony-stimulating factor(GM-CSF) IL10, MIP1B, IFNγ, TNFα, RANTES, IL6, IL10 | Encephalopathy, Acute disseminated encephalomyelitis, Myelitis, Neuritis brachialis, Stroke, Neuro thalamic complications acute hypokalemic paralysis |
Inflammatory signatures of viruses and their neurological outcomes.
Herpes Simplex Virus (HSV-1) is one of the most common DNA viruses that affects almost a quarter of pregnant women worldwide during different stages of pregnancy. HSV-1 has been recognized as one of the significant causes of neurodevelopmental disabilities in children who are exposed prenatally (Straface et al., 2012). Primary infection of HSV-1 is usually asymptomatic and the risk of neonatal infection rises as the pregnancy progresses. On the other hand, HSV-2 infection is relatively uncommon but has been implicated in ASD (Straface et al., 2012). The other large DNA virus also belonging to the Herpesviridae, namely Cytomegalovirus (CMV) is a major public health issue leading to lifelong latent infection (Cheeran et al., 2009; Jackson et al., 2011). The vertical transmission risk of CMV is 30–40% of which infection during the first trimester of pregnancy is a prognostic for sensorineural loss and neuropsychological disorders such as schizophrenia in infants (Adler et al., 2007). The Human Immunodeficiency Virus (HIV) is also known to cause neurodevelopmental and neuropsychiatric disorders (Ghafouri et al., 2006; Van Rie et al., 2008).
RNA viruses, primarily of the Flaviviridae family are known to be neurotropic pathogens (Pierson and Diamond, 2020). The most recent outbreak was caused by Zika virus (ZKV), which was mildly febrile in adults but induced severe developmental defects like microcephaly in progeny (Krauer et al., 2017). Other related flaviviruses such as West Nile Virus (WNV), Japanese Encephalitis Virus (JEV) and Dengue virus (DENV) have much lower rates of vertical transmission, but are neurotropic (Li et al., 2017). Once they cross the placental barrier, viruses can breach fetal brain barriers through diverse mechanisms (Ayala-Nunez and Gaudin, 2020) (Figure 1). Polio and measles viruses (Oglesbee and Niewiesk, 2011; Ohka et al., 2012) can directly infect and lyse the endothelial and epithelial cells of the BBB and enter the brain parenchyma directly. The most common mechanism appears to be the downregulation of different tight junction proteins such as occludin and claudin that constitute the barrier. Neurotropic viruses such as WNV, HSV1 and ZKV, affect the barrier integrity by the downregulation of tight junction proteins, mediated by secretory cytokines such as TNFα (Verma et al., 2009; Chiu et al., 2020; He et al., 2020). JEV and DENV can damage the BBB by downregulating tight junction proteins by disrupting the endothelial glycocalyx (Puerta-Guardo et al., 2016). Cell free viruses such as HIV and ZKV enter the BBB via transcytotic or paracellular pathways, without compromising the membrane integrity (Agrawal et al., 2013; Calderón-Peláez et al., 2019). Another prevalent mode involves trojan horse like mechanism, where the virus infects lymphocytes or monocytes in the peripheral parts of the body that can migrate into the brain by paracellular or transcellular pathway to cross the BBB (Kim et al., 2003). For instance, HIV1 infected CD4+T cells, HTLV1 infected CD8+T cells and ZKV infected monocytes can all infiltrate the brain parenchyma. In the case of HSV1, the virions can also directly enter CNS via anterograde transport to reach the axonal shaft and tip in the neuronal periphery, where they are released (Kim et al., 2003; Ayala-Nunez et al., 2019). The more recent outbreak of SARS CoV2, though rarely transmitted to the fetus, can break the BSCF barrier by infecting epithelial cells expressing ACE2 receptor (Pellegrini et al., 2020). Compared to the BBB, the tight junctions in BCSFB are more prone to microbial penetration due to the nature of epithelial cells (Redzic, 2011; Dando et al., 2014). The “leaky barriers” of the brain not only allow the invasion of viruses, but also are amenable for invasion by the peripheral immune components and secretory proteins, which can lead to an altered redox state in the brain. The dysfunctional BBB has been implicated in a number of neurodevelopmental disorders such as seizures, epilepsy, and schizophrenia (Kealy et al., 2020). Viruses such as HSV1 and CMV which are latent upon entry in fetuses, can reactivate postnatally and compromise the permeability of BBB by activating microglia and mounting inflammatory response, resulting in massive influx of other signaling molecules and peripheral immune components into the brain. This initiates a string of pernicious events ultimately leading to decline of brain functions such as cognition and memory. Thus, it would be interesting to compare and contrast different viral neuroinflammatory signatures caused by minor changes in barrier composition vs. total barrier breakdown. Identifying mechanisms as to how the BBB can repair itself will also have implications in designing effective intervention strategies.
Molecular Basis of Virus-Induced Neurodevelopmental Disorders
How do distinct pathogens manifest different pathological outcomes in terms of neurological disorders? Small motifs called Pathogen associated molecular patterns (PAMPs) unique to each pathogen is sensed by pattern receptors (PRR) such as Toll like receptor (TLRs), which trigger different inflammatory reactions. These in turn translate into different developmental abnormalities (Figure 3).
FIGURE 3
When there is a productive infection, the maternal immune system is activated, resulting in systemic inflammation, mediated by cytokine release. While the inflammatory cytokines can cross the placental and BBB barriers and are thought to be protective, they can also have detrimental effects (Banks et al., 1995). Proinflammatory cytokine signatures are frequently linked to a variety of neurological disorders including microcephaly, cerebral palsy, schizophrenia and ASD (Ratnayake et al., 2013). Direct injection of pro-inflammatory cytokines such as IL1β and TNFα into the brains of mice, for example, resulted in social withdrawal, altered cognition and diurnal rhythm. In contrast, Insulin Growth factor 1 or IL10 injections attenuated the sickness behavior (Bluthé et al., 2000) alluding to the role of balance in pro- and anti-inflammatory cytokines in orchestration of behavior (Munshi et al., 2019). Such association of cytokines with sickness behavior has also been observed in humans, especially in individuals diagnosed with depression, schizophrenia and autism. Individuals with these neurological conditions exhibit elevated serum anti-inflammatory cytokines such as IL6, IL2R, IFN, IL13, TGF, and IL1 (Knuesel et al., 2014; Xu et al., 2015; Jiang et al., 2018). IL6, the most commonly secreted cytokine during infection, has the potential to alter the cognitive behavior of the progeny to an extent that there is a negative correlation between maternal IL6 and the memory of young children (Smith et al., 2007; Wu et al., 2015; Rudolph et al., 2018). Similarly, elevated levels of CXCL8 (IL8), and TNFα as well as the acute phase protein C-reactive protein (CRP) in maternal serum are linked to an increased risk of schizophrenia in offspring (Buka et al., 2001; Brown et al., 2004). Notably, the interplay between pro-inflammatory cytokines such as TLR4, IL1, IL6 and TNFα released upon maternal infection during pregnancy and preterm births is well established (Pandey et al., 2017). Increased secretion of cytokines such as IL8, IL1β and CRP have been linked with microcephaly, ventriculomegaly and low intelligence quotient (Dammann and O’Shea, 2008; Leviton et al., 2016). Thus, the neurological consequences of many viral infections may be related to the cytokines released rather than the viruses themselves.
In fact, the timing of maternal infection is crucial to the neurodevelopmental outcomes (Solek et al., 2018). Mimicking viral infection by the use of poly I:C at gestation day (GD) 9 or GD17 (early vs. mid stage gestation) in mice showed that while GD 9 infected mice off-springs showed defective spatial exploration, GD17 infected offsprings displayed preservative behavior reflecting autism (Meyer et al., 2006). Similarly, immune challenge in early-mid gestational period leads to increased activation of TNFα and IL10 which is associated with increased postnatal apoptosis (Meyer et al., 2006). Thus immunological challenges at different times of prenatal development may have adverse but variable neurodevelopmental manifestations (Meyer et al., 2007). Therefore, the local immune response in the brain has to be stringently modulated to prevent a huge cytolytic damage, since majority of the cells in CNS (neurons) are non-renewable and terminally differentiated.
Inflammatory Signatures of Viruses
Do all viral infections elicit similar cytokine profiles? Interestingly, all viruses tend to elicit similar pro-inflammatory cytokines. However, each virus elicits different responses in different cell types based on the type of receptors (Table 1). Upon infection, maternal immune activation produces significant amounts of pro-inflammatory cytokines, many of which including IL6, TNFα, IL10 and IL1β can be detected in the fetal brain (Meyer et al., 2009). This occurs due to the response of different CNS cell types such as neurons, astrocytes and glial cells to the cytokines and infections. Most of these cells have specialized surface receptors such as TLRs (Okun et al., 2011), retinoic acid inducible gene I (RIG) like receptors (Loo and Gale, 2011), mitochondrial antiviral signaling (MAVS) (Nair and Diamond, 2016) and cytokine receptors (Perry et al., 2010). However, differences in the pathogen spread and persistence varies based on the expression levels of each of these immune receptors, expression of innate immune genes and the extent of IFN1 response (Cho et al., 2013). For instance, early cortical neurons which have lower levels of RIG1 are more permissive to WNV and ZKV while in hippocampal neurons high basal expression of type I IFN can restrict varicella virus (Cho et al., 2013; Kennedy et al., 2015). Although HSV1 and ZKV deplete neural progenitor pools and cause a similar phenotype, namely microcephaly, they engage different molecular mechanisms. HSV1 perturbs neuroepithelial polarity and is more severe, while ZKV affects neural progenitor cells without altering the polarity. Furthermore, the sensitivity of ZKV and HSV1 to IFN1 significantly varies, with HSV1 being able to neutralise IFNb unlike ZKV (Krenn et al., 2021).
The predominant host response mechanism that is triggered by several viral infections is the activation of microglia. Fetal microglia differ from adult microglia in their morphology and gene expression profiles (Ginhoux et al., 2013; Kracht et al., 2020). Maternal immune activation with poly I:C in mice revealed that the offspring had an early push toward a more mature microglial developmental state, with a number of autism susceptibility genes differentially expressed (Ozaki et al., 2020). Thus, when maternal immune activation occurs at early gestation, the changes can be sustained in microglia for a longer duration resulting in rewired neural circuits. This rewiring is linked to behavioral defects seen postnatally. While an increased number of activated microglia is essential to stave off infectious agents, a prolonged activation is detrimental leading to neurodevelopmental disorders (Czeh et al., 2011). This is not due to an increase in microglia, but because their immune response is skewed toward a pro-inflammatory state, thereby exposing the fetal and postnatal brain to neuronal loss (Y. S. Kim and Joh, 2006). Once activated, microglia can secrete complement components, the uncontrolled secretion of which could result in abnormal synaptic pruning. This is well exemplified by the fact that the injection of the mouse with poly I:C triggered sustained complement subcomponent C1q secretion in the prefrontal cortex of offspring which often coats the synapse to be eliminated (Han et al., 2017). Notably, mice defective for C1q and CX3CR1 exhibit enhanced excitatory synaptic connectivity similar to those observed in subsets of ASD patients (Chu et al., 2010; Paolicelli et al., 2011; Fagan et al., 2017). The sequestration or inactivation of the complement cascade employed by viruses as an evasion strategy could thus play an indirect role in manifestation of neurodevelopmental disorders (Stoermer and Morrison, 2011).
The source of cytokines in brain is not limited to the resident immune cells but includes immune cells that migrate to the brain guided by chemokine secretion. These peripheral immune cells additionally contribute to an increased production of cytokines in the brain. For example, CXCL10 is overexpressed during a flaviviral infections such ZKV, DENV and WNV and attracts CD-8+ T-cells as a protective mechanism (Klein et al., 2005). However, too much of CXCL10 causes an increase in intracellular calcium levels and triggers apoptosis (Sui et al., 2006). Other chemokines such as CCL4, CCL5 are also significantly upregulated while CCL2 and CXCL8 are significantly downregulated. Interestingly, latent infections can also produce these chemokines which explains the immune infiltration seen in certain cases (Melchjorsen et al., 2003). While the interaction of peripheral immune cell signaling with microglia during viral infections confers protection, it can indirectly damage CNS through synaptic stripping and neuronal death by stimulating neurons to produce CCL2, which acts as a receptor for microglia to phagocytose them (Di Liberto et al., 2018; Moseman et al., 2020).
Transcriptome profiles of host immune cells post-viral infections reveal the upregulation of interferon-stimulated gene family (ISGs) and cell type specific pro-inflammatory genes. For example, CMV-infected pericytes show an upregulation of RANTES, IL6, IL7, IL11, and cyclooxygenase 2 (COX-2) (Cheeran et al., 2001; Zhu et al., 2001). Infected astrocytes predominantly express CCL2 and show TGFβ activation while microglia produce TNFα, IL6 alongside CXCL10, CCL2, CCL3, and CCL5. In such instances, production of anti-inflammatory cytokines such as IL10 is paramount to negate the detrimental consequences of neuroinflammation. This is reflected by the association of genetic variation in IL10 gene with altered HCMV disease occurrence following allogeneic stem cell transplantation and HIV co-infection (Sezgin et al., 2010).
The common presumption that increased production and release of pro-inflammatory cytokines into the fetus can cause brain damage has now been refined. A slender shift in the excess pro- or anti-inflammatory cytokines during an infectious response is sufficient to disrupt normal brain development (Deverman and Patterson, 2009). Contrarily, a uniform change in the expression of pro and anti-inflammatory cytokines such as IL6 and IL10, do not alter post-natal abnormalities, as observed in mice (Meyer et al., 2009). Importantly, viral genomes constantly and rapidly evolve to evade host immune surveillance, resulting in viral proteins mimicking and/or degrading critical immune modulatory signaling pathways. As a case in point, during the viral lytic cycle, CMV produces a functional ortholog of IL10 (UL111A, vIL10) that can suppress a number of innate and adaptive host immune responses including pro-inflammatory cytokine secretion (Jenkins et al., 2004). In the case of ZKV, the RdRP NS5 protein binds to and degrades STAT2 which is essential for IFN1 response (Kumar et al., 2016). HSV1 on the other hand uses the Infected Cell Protein 0 to engage with the host proteasome pathway to degrade Interferon-Stimulated Gene (ISG) products (Van Sant et al., 2001). Additionally, HSV1 prevents the phosphorylation of eukaryotic initiation factor 2, required for translation, by blocking Protein kinase R and recruiting protein phosphatase 1a by the viral protein ICP34.5 (Li et al., 2011). DNA viruses, specifically Herpesviruses and Poxviruses, circumvent interferon response by making their own soluble viroceptors/virokines, which can intercept the activities of host cytokines by sequestering them (Smith and Kotwal, 2001). This is exemplified by the binding of the poxvirus protein B8R to IFNγ which attenuates the inflammatory response (Johnston and McFadden, 2003). Emulating this, IFNγ peptide mimetics have been engineered which can circumvent the binding by B8R and be used as an antiviral therapeutic (Ahmed et al., 2005).
Sexual Dichotomy in Neuroinflammation and Neurological Outcomes
Gender differences in the severity and prevalence of different viral infections are another confounding factor in determining the outcomes of inflammatory responses (Klein and Flanagan, 2016; Mallard et al., 2019). Studies suggest that female fetuses are more resistant to intra-uterine stress and that the male offspring’s immunological homeostasis is particularly affected by maternal immune activation (Goldenberg et al., 2006; Zager et al., 2013). This sexual dimorphism adds complexity to neurological outcomes (Nelson and Lenz, 2017). Males have been shown to be more susceptible to ASD, ADHD, schizophrenia, and bipolar disorder than females (Werling and Geschwind, 2013; Werling, 2016). Males have a faster microglial maturation pathway, which is connected with differential gene expression of immune-related genes (Hanamsagar et al., 2017). While the inherent differences between the male and the female immune systems such as elevated Type I IFN response, T cell numbers, TLR3 response could play a role (Chavez-Valdez et al., 2019), it remains unclear if the transmission risks are the same between the male and the female progeny. Furthermore, differences in immunological regulation between males and females due to glucocorticoid-stimulated cytokine release may also contribute to the sexual dichotomy of the neuroendocrine axis (Bailey et al., 2003; Silverman et al., 2005; Duma et al., 2010). A sustained increase in cytokine production can cause the pituitary to secrete adrenocorticotropic hormone (ACTH), which causes the adrenal gland to release cortisol. Cortisol levels above a certain threshold can harm the hippocampus, affecting learning and memory and promote atrophy in the HPA, hippocampus, and amygdala (Sroykham and Wongsawat, 2019).
Conclusion and Outlook
Understanding the role of inflammation in neurodevelopmental disorders has now opened up avenues for targeting the immune system of patients with neuropsychiatric disorders such as bipolar disorder, ASD and schizophrenia. For example, the two drugs risperidone and aripiprazole now approved for treatment to improve irritability in ASD and schizophrenia have shown to possess anti-inflammatory effects (Juncal-Ruiz et al., 2018). Likewise use of anti-inflammatory drugs such as minocycline and pioglitazone are being explored to improve irritability and depressive behaviors (Rosenblat, 2019). Thus, a systematic approach to characterizing the molecular and cellular effects of these antipsychotic drugs on inflammation, as well as correlating their clinical response, will pave the way for effective combinatorial therapies, in case of neurodevelopmental disorders with immune dysregulation. Likewise, specific non-steroidal anti-inflammatory drugs (NSAID) such as naproxen have been shown to be effective against ZKV entry (Pan et al., 2018), Influenza virus (Dilly et al., 2018) and reactivation of HSV-1 at least in cellular models. However, this use needs to be exercised with caution since NSAIDs can have diverse effects in addition to their modulation of microglial activation (Ajmone-Cat et al., 2010).
Prenatal exposure to maternal immune activation has been recognized as a risk factor for adverse neurological outcomes by a number of preclinical and epidemiological studies. However, an in depth molecular understanding of how the prenatal exposure to immune activation results in offspring’s neuronal and cognitive impairments in different stages of gestation is lacking. Targeting multiple inflammatory indicators at various times during pregnancy after viral infections will be needed for the development of successful neurodevelopmental disorder therapies. For example, most of the viral infections or neurological diseases show elevated levels of TNFα. Thus intuitively neutralizing this cytokine could ameliorate or prevent the disorder. However, studies thus far have reported discordant findings in this regard. While in murine CMV model and WNV infection model, TNFα antagonist indeed rectified cerebellar abnormalities and developmental gene expression, it has been found to augment Multiple Sclerosis phenotype in humans by increasing peripheral and CNS autoimmunity (Sicotte and Voskuhl, 2001; Shrestha et al., 2008). Although acute infection can be cleared by drug treatment, the extant immune responses, even after pathogen clearance, could cause long-term psychiatric and neurocognitive issues in survivors (Klein et al., 2017). Since many neurodevelopmental disorders have intermediate phenotypes and are subjective, the adoption of multiple complementary methods such as neurochemical investigations and cytokine profiles for accurate diagnosis is necessary. In this regard, use of a powerful platform such as 3D brain organoids with an integrated neuroendocrine and neuro-immune axis should aid to unravel how different viral infections can induce diverse immune gene expression programs in a spatiotemporal manner (Krenn et al., 2021).
Despite the fact that a link between intrauterine viral infections and neurodevelopmental disorders has been established, our ability to prevent or correct such abnormalities using pharmaceutical interventions has been limited. Several studies have shown that regardless of the virus, maternal immune activation and subsequent inflammatory response may be a key determinant of neurological outcomes. Therefore, elucidating the gestation stage specific and sex specific effects of viral infection, as well as inflammatory response codes for various viruses would allow for the development of early diagnosis and intervention strategies for neurodevelopmental disorders.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Statements
Author contributions
PLC designed the structure and contents of the review. SG and PLC prepared the figures and wrote the manuscript. Both authors contributed to the article and approved the submitted version.
Funding
PLC is supported by Wellcome Trust Indian alliance intermediate grant (IA/I/19/1/504280) and SERB Women Excellence Award (WEA/2020/000026). SG is supported by CSIR Senior Research Fellowship.
Acknowledgments
The authors would like to thank Sreenivas Chavali, IISER Tirupati for critical inputs during manuscript preparation. Figures were created with BioRender.com.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Abbreviations
- ASD
autism spectrum disorder
- BBB
Blood Brain Barrier
- BCSFB
Blood CSF Barrier
- CMV
Cytomegalovirus
- CNS
central nervous system
- CSF
cerebrospinal fluid
- HSV
Herpes Simplex Virus
- HIV
human immunodeficiency virus
- HTLV-1
human T-lymphotropic virus 1
- IFN
interferon
- IL
interleukin
- JEV
Japanese encephalitis virus
- WNV
West Nile virus
- ZKV
Zika virus.
References
1
AarumJ.SandbergK.HaeberleinS. L. B.PerssonM. A. A. (2003). Migration and differentiation of neural precursor cells can be directed by microglia.Proc. Natl. Acad. Sci. U.S.A.10015983–15988. 10.1073/pnas.2237050100
2
AbbottN. J.PatabendigeA. A. K.DolmanD. E. M.YusofS. R.BegleyD. J. (2010). Structure and function of the blood-brain barrier.Neurobiol. Dis.3713–25. 10.1016/j.nbd.2009.07.030
3
AdlerS. P.NigroG.PereiraL. (2007). Recent advances in the prevention and treatment of congenital cytomegalovirus infections.Semin. Perinatol.3110–18. 10.1053/j.semperi.2007.01.002
4
AgrawalT.SharvaniV.NairD.MedigeshiG. R. (2013). Japanese encephalitis virus disrupts cell-cell junctions and affects the epithelial permeability barrier functions.PLoS One8:e69465. 10.1371/journal.pone.0069465
5
AhmedC. M. I.BurkhartM. A.SubramaniamP. S.MujtabaM. G.JohnsonH. M. (2005). Peptide mimetics of gamma interferon possess antiviral properties against vaccinia virus and other viruses in the presence of poxvirus B8R protein.J. Virol.795632–5639. 10.1128/JVI.79.9.5632-5639.2005
6
Ajmone-CatM. A.BernardoA.GrecoA.MinghettiL. (2010). Non-steroidal anti-inflammatory drugs and brain inflammation: effects on microglial functions.Pharmaceuticals (Basel)31949–1965. 10.3390/ph3061949
7
Al-SadiR.BoivinM.MaT. (2009). Mechanism of cytokine modulation of epithelial tight junction barrier.Front. Biosci. (Landmark Ed.)14:2765–2778. 10.2741/3413
8
AyalaR.ShuT.TsaiL. H. (2007). Trekking across the brain: the journey of neuronal migration.Cell12829–43. 10.1016/j.cell.2006.12.021
9
Ayala-NunezN. V.FollainG.DelalandeF.HirschlerA.PartiotE.HaleG. L.et al (2019). Zika virus enhances monocyte adhesion and transmigration favoring viral dissemination to neural cells.Nat. Commun.10:4430. 10.1038/s41467-019-12408-x
10
Ayala-NunezN. V.GaudinR. (2020). A viral journey to the brain: current considerations and future developments.PLoS Pathog.16:e1008434. 10.1371/journal.ppat.1008434
11
AzevedoF. A. C.CarvalhoL. R. B.GrinbergL. T.FarfelJ. M.FerrettiR. E. L.LeiteR. E. P.et al (2009). Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain.J. Comp. Neurol.513532–541. 10.1002/cne.21974
12
BaileyM.EnglerH.HunzekerJ.SheridanJ. F. (2003). The hypothalamic-pituitary-adrenal axis and viral infection.Viral Immunol.16141–157. 10.1089/088282403322017884
13
BallabhP.BraunA.NedergaardM. (2004). The blood-brain barrier: an overview: structure, regulation, and clinical implications.Neurobiol. Dis.161–13. 10.1016/j.nbd.2003.12.016
14
BanksW. A.KastinA. J.BroadwellR. D. (1995). Passage of cytokines across the blood-brain barrier.Neuroimmunomodulation2241–248. 10.1159/000097202
15
BiberK.NeumannH.InoueK.BoddekeH. W. G. M. (2007). Neuronal “On” and “Off” signals control microglia.Trends Neurosci.30596–602. 10.1016/j.tins.2007.08.007
16
BluthéR. M.LayéS.MichaudB.CombeC.DantzerR.ParnetP. (2000). Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice.Eur. J. Neurosci.124447–4456.
17
BrownA. S.HootonJ.SchaeferC. A.ZhangH.PetkovaE.BabulasV.et al (2004). Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring.Am. J. Psychiatry161889–895. 10.1176/appi.ajp.161.5.889
18
BukaS. L.TsuangM. T.TorreyE. F.KlebanoffM. A.WagnerR. L.YolkenR. H. (2001). Maternal cytokine levels during pregnancy and adult psychosis.Brain Behav. Immun.15411–420. 10.1006/brbi.2001.0644
19
BushmanD. M.ChunJ. (2013). The genomically mosaic brain: aneuploidy and more in neural diversity and disease.Semin. Cell Dev. Biol.24357–369. 10.1016/j.semcdb.2013.02.003
20
Calderón-PeláezM.-A.Velandia-RomeroM. L.Bastidas-LegardaL. Y.BeltránE. O.Camacho-OrtegaS. J.CastellanosJ. E. (2019). Dengue virus infection of blood–brain barrier cells: consequences of severe disease.Front. Microbiol.10:1435. 10.3389/fmicb.2019.01435
21
CebriánC.LoikeJ. D.SulzerD. (2014). Neuronal MHC-I expression and its implications in synaptic function, axonal regeneration and Parkinson’s and other brain diseases.Front. Neuroanat.8:114. 10.3389/fnana.2014.00114
22
ChambersR. A.PotenzaM. N.HoffmanR. E.MirankerW. (2004). Simulated apoptosis/neurogenesis regulates learning and memory capabilities of adaptive neural networks.Neuropsychopharmacology29747–758. 10.1038/sj.npp.1300358
23
ChanC. J.HeisenbergC. P.HiiragiT. (2017). Coordination of morphogenesis and cell-fate specification in development.Curr. Biol.27R1024–R1035. 10.1016/j.cub.2017.07.010
24
ChavaliP. L.PützM.GergelyF. (2014). Small organelle, big responsibility: the role of centrosomes in development and disease.Philos. Trans. R. Soc. Lond. B Biol. Sci.369:20130468. 10.1098/rstb.2013.0468
25
Chavez-ValdezR.MottahedinA.StridhL.YellowhairT. R.JantzieL. L.NorthingtonF. J.et al (2019). Evidence for sexual dimorphism in the response to TLR3 activation in the developing neonatal mouse brain: a pilot study.Front. Physiol.10:306. 10.3389/fphys.2019.00306
26
CheeranM. C.HuS.YagerS. L.GekkerG.PetersonP. K.LokensgardJ. R. (2001). Cytomegalovirus induces cytokine and chemokine production differentially in microglia and astrocytes: antiviral implications.J. Neurovirol.7135–147. 10.1080/13550280152058799
27
CheeranM. C.-J.LokensgardJ. R.SchleissM. R. (2009). Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention.Clin. Microbiol. Rev.2299–126. 10.1128/CMR.00023-08
28
ChessS. (1971). Autism in children with congenital rubella.J. Autism Child. Schizophr.133–47. 10.1007/BF01537741
29
ChiuC.-F.ChuL.-W.LiaoI.-C.SimanjuntakY.LinY.-L.JuanC.-C.et al (2020). The mechanism of the Zika virus crossing the placental barrier and the blood-brain barrier.Front. Microbiol.11:214. 10.3389/fmicb.2020.00214
30
ChoH.ProllS. C.SzretterK. J.KatzeM. G.GaleM. J.DiamondM. S. (2013). Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positive-stranded RNA viruses.Nat. Med.19458–464. 10.1038/nm.3108
31
ChuY.JinX.ParadaI.PesicA.StevensB.BarresB.et al (2010). Enhanced synaptic connectivity and epilepsy in C1q knockout mice.Proc. Natl. Acad. Sci. U.S.A.1077975–7980. 10.1073/pnas.0913449107
32
ClarkeP. G.PosadaA.PrimiM. P.CastagnéV. (1998). Neuronal death in the central nervous system during development.Biomed. Pharmacother.52356–362. 10.1016/s0753-3322(99)80002-x
33
ColonnaM.ButovskyO. (2017). Microglia function in the central nervous system during health and neurodegeneration.Annu. Rev. Immunol.35441–468. 10.1146/annurev-immunol-051116-052358
34
CourchesneE.MoutonP. R.CalhounM. E.SemendeferiK.Ahrens-BarbeauC.HalletM. J.et al (2011). Neuron number and size in prefrontal cortex of children with autism.JAMA3062001–2010. 10.1001/jama.2011.1638
35
CunninghamC. L.Martínez-CerdeñoV.NoctorS. C. (2013). Microglia regulate the number of neural precursor cells in the developing cerebral cortex.J. Neurosci.334216–4233. 10.1523/JNEUROSCI.3441-12.2013
36
CzehM.GressensP.KaindlA. M. (2011). The Yin and Yang of microglia.Dev. Neurosci.33199–209. 10.1159/000328989
37
DammannO.O’SheaT. M. (2008). Cytokines and perinatal brain damage.Clin. Perinatol.35643–663,v. 10.1016/j.clp.2008.07.011
38
DandoS. J.Mackay-SimA.NortonR.CurrieB. J.St JohnJ. A.EkbergJ. A. K.et al (2014). Pathogens penetrating the central nervous system: infection pathways and the cellular and molecular mechanisms of invasion.Clin. Microbiol. Rev.27691–726. 10.1128/CMR.00118-13
39
DanemanR.PratA. (2015). The blood-brain barrier.Cold Spring Harb. Perspect. Biol.7:a020412. 10.1101/cshperspect.a020412
40
DanielsB. P.KleinR. S. (2015). Knocking on closed doors: host interferons dynamically regulate blood-brain barrier function during viral infections of the central nervous system.PLoS Pathog.11:e1005096. 10.1371/journal.ppat.1005096
41
DevermanB. E.PattersonP. H. (2009). Cytokines and CNS development.Neuron6461–78. 10.1016/j.neuron.2009.09.002
42
Di LibertoG.PantelyushinS.KreutzfeldtM.PageN.MusardoS.CorasR.et al (2018). Neurons under T cell attack coordinate phagocyte-mediated synaptic stripping.Cell175458–471.e19. 10.1016/j.cell.2018.07.049
43
DillyS.Fotso FotsoA.LejalN.ZeddaG.ChebboM.RahmanF.et al (2018). From naproxen repurposing to naproxen analogues and their antiviral activity against influenza A virus.J. Med. Chem.617202–7217. 10.1021/acs.jmedchem.8b00557
44
DudikiT.MellerJ.MahajanG.LiuH.ZhevlakovaI.SteflS.et al (2020). Microglia control vascular architecture via a TGFβ1 dependent paracrine mechanism linked to tissue mechanics.Nat. Commun.11:986. 10.1038/s41467-020-14787-y
45
DumaD.CollinsJ. B.ChouJ. W.CidlowskiJ. A. (2010). Sexually dimorphic actions of glucocorticoids provide a link to inflammatory diseases with gender differences in prevalence.Sci. Signal.3:ra74. 10.1126/scisignal.2001077
46
DziembowskaM.ThamT. N.LauP.VitryS.LazariniF.Dubois-DalcqM. (2005). A role for CXCR4 signaling in survival and migration of neural and oligodendrocyte precursors.Glia50258–269. 10.1002/glia.20170
47
ElshazzlyM.CabanO. (2019). “Embryology, central nervous system,” in StatPearls, (Treasure Island, FL: StatPearls Publishing).
48
FaganK.CriderA.AhmedA. O.PillaiA. (2017). Complement C3 expression is decreased in autism spectrum disorder subjects and contributes to behavioral deficits in rodents.Mol. Neuropsychiatry319–27. 10.1159/000465523
49
FangW.-Q.ChenW.-W.JiangL.LiuK.YungW.-H.FuA. K. Y.et al (2014). Overproduction of upper-layer neurons in the neocortex leads to autism-like features in mice.Cell Rep.91635–1643. 10.1016/j.celrep.2014.11.003
50
FenstermacherJ. D. (1980). Comparative aspects of blood-brain exchange.Fed. Proc.393201–3206.
51
FreidinM.BennettM. V.KesslerJ. A. (1992). Cultured sympathetic neurons synthesize and release the cytokine interleukin 1 beta.Proc. Natl Acad. Sci. U.S.A.8910440–10443. 10.1073/pnas.89.21.10440
52
GalicM. A.RiaziK.PittmanQ. J. (2012). Cytokines and brain excitability.Front. Neuroendocrinol.33:116–125. 10.1016/j.yfrne.2011.12.002
53
GarayP. A.McAllisterA. K. (2010). Novel roles for immune molecules in neural development: implications for neurodevelopmental disorders.Front. Synaptic Neurosci.2:136. 10.3389/fnsyn.2010.00136
54
GaserC.NenadicI.BuchsbaumB. R.HazlettE. A.BuchsbaumM. S. (2004). Ventricular enlargement in schizophrenia related to volume reduction of the thalamus, striatum, and superior temporal cortex.Am. J. Psychiatry161154–156. 10.1176/appi.ajp.161.1.154
55
GhafouriM.AminiS.KhaliliK.SawayaB. E. (2006). HIV-1 associated dementia: symptoms and causes.Retrovirology3:28. 10.1186/1742-4690-3-28
56
GinhouxF.LimS.HoeffelG.LowD.HuberT. (2013). Origin and differentiation of microglia.Front. Cell. Neurosci.7:45. 10.3389/fncel.2013.00045
57
GoldenbergR. L.AndrewsW. W.Faye-PetersenO.CliverS.GoepfertA. R.HauthJ. C. (2006). The alabama preterm birth project: placental histology in recurrent spontaneous and indicated preterm birth.Am. J. Obstet. Gynecol.195792–796. 10.1016/j.ajog.2006.05.050
58
GötzM.HuttnerW. B. (2005). The cell biology of neurogenesis.Nat. Rev. Mol. Cell Biol.6777–788. 10.1038/nrm1739
59
HanM.ZhangJ.-C.HashimotoK. (2017). Increased levels of C1q in the prefrontal cortex of adult offspring after maternal immune activation: prevention by 7,8-dihydroxyflavone.Clin. Psychopharmacol. Neurosci.1564–67. 10.9758/cpn.2017.15.1.64
60
HanamsagarR.AlterM. D.BlockC. S.SullivanH.BoltonJ. L.BilboS. D. (2017). Generation of a microglial developmental index in mice and in humans reveals a sex difference in maturation and immune reactivity.Glia651504–1520. 10.1002/glia.23176
61
HanischU.-K. (2002). Microglia as a source and target of cytokines.Glia40140–155. 10.1002/glia.10161
62
HarrisonJ. K.JiangY.ChenS.XiaY.MaciejewskiD.McNamaraR. K.et al (1998). Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia.Proc. Natl. Acad. Sci. U.S.A.9510896–10901. 10.1073/pnas.95.18.10896
63
HeQ.LiuH.HuangC.WangR.LuoM.LuW. (2020). Herpes simplex virus 1-induced blood-brain barrier damage involves apoptosis associated with GM130-mediated golgi stress.Front. Mol. Neurosci.13:2. 10.3389/fnmol.2020.00002
64
HeffernanA. L.HareD. J. (2018). Tracing environmental exposure from neurodevelopment to neurodegeneration.Trends Neurosci.41496–501. 10.1016/j.tins.2018.04.005
65
Herculano-HouzelS. (2009). The human brain in numbers: a linearly scaled-up primate brain.Front. Hum. Neurosci.3:31. 10.3389/neuro.09.031.2009
66
HuttnerW. B.KosodoY. (2005). Symmetric versus asymmetric cell division during neurogenesis in the developing vertebrate central nervous system.Curr. Opin. Cell Biol.17648–657. 10.1016/j.ceb.2005.10.005
67
HuttonJ. (2016). Does rubella cause autism: a 2015 reappraisal?Front. Hum. Neurosci.10:25. 10.3389/fnhum.2016.00025
68
IliffJ. J.WangM.LiaoY.PloggB. A.PengW.GundersenG. A.et al (2012). A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β.Sci. Transl. Med.4:147ra111. 10.1126/scitranslmed.3003748
69
JacksonS. E.MasonG. M.WillsM. R. (2011). Human cytomegalovirus immunity and immune evasion.Virus Res.157151–160. 10.1016/j.virusres.2010.10.031
70
JarskogL. F.GlantzL. A.GilmoreJ. H.LiebermanJ. A. (2005). Apoptotic mechanisms in the pathophysiology of schizophrenia.Prog. Neuropsychopharmacol. Biol. Psychiatry29846–858. 10.1016/j.pnpbp.2005.03.010
71
JenkinsC.AbendrothA.SlobedmanB. (2004). A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection.J. Virol.781440–1447. 10.1128/jvi.78.3.1440-1447.2004
72
JiangN. M.CowanM.MoonahS. N.PetriW. A. J. (2018). The impact of systemic inflammation on neurodevelopment.Trends Mol. Med.24794–804. 10.1016/j.molmed.2018.06.008
73
JohnstonJ. B.McFaddenG. (2003). Poxvirus immunomodulatory strategies: current perspectives.J. Virol.776093–6100. 10.1128/jvi.77.11.6093-6100.2003
74
Juncal-RuizM.Riesco-DávilaL.Ortiz-García de la FozV.Martínez-GarciaO.Ramírez-BonillaM.Ocejo-ViñalsJ. G.et al (2018). Comparison of the anti-inflammatory effect of aripiprazole and risperidone in 75 drug-naïve first episode psychosis individuals: a 3 months randomized study.Schizophr. Res.202226–233. 10.1016/j.schres.2018.06.039
75
KangH. J.KawasawaY. I.ChengF.ZhuY.XuX.LiM.et al (2011). Spatio-temporal transcriptome of the human brain.Nature478483–489. 10.1038/nature10523
76
KanoldP. O. (2009). Subplate neurons: crucial regulators of cortical development and plasticity.Front. Neuroanat.3:16. 10.3389/neuro.05.016.2009
77
KealyJ.GreeneC.CampbellM. (2020). Blood-brain barrier regulation in psychiatric disorders.Neurosci. Lett.726:133664. 10.1016/j.neulet.2018.06.033
78
KendellR. E.KempI. W. (1989). Maternal influenza in the etiology of schizophrenia.Arch. Gen. Psychiatry46878–882. 10.1001/archpsyc.1989.01810100020004
79
KennedyP. G. E.RovnakJ.BadaniH.CohrsR. J. (2015). A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation.J. Gen. Virol.96(Pt 7)1581–1602. 10.1099/vir.0.000128
80
KimW.-K.CoreyS.AlvarezX.WilliamsK. (2003). Monocyte/macrophage traffic in HIV and SIV encephalitis.J. Leukoc. Biol.74650–656. 10.1189/jlb.0503207
81
KimY. S.JohT. H. (2006). Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson’s disease.Exp. Mol. Med.38333–347.
82
KipnisJ. (2016). Multifaceted interactions between adaptive immunity and the central nervous system.Science (New York, N.Y.)353766–771. 10.1126/science.aag2638
83
KleinR. S.GarberC.HowardN. (2017). Infectious immunity in the central nervous system and brain function.Nat. Immunol.18132–141. 10.1038/ni.3656
84
KleinR. S.LinE.ZhangB.LusterA. D.TollettJ.SamuelM. A.et al (2005). Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis.J. Virol.7911457–11466. 10.1128/JVI.79.17.11457-11466.2005
85
KleinS. L.FlanaganK. L. (2016). Sex differences in immune responses.Nat. Rev. Immunol.16626–638. 10.1038/nri.2016.90
86
KnoblichJ. A. (2008). Mechanisms of asymmetric stem cell division.Cell132583–597. 10.1016/j.cell.2008.02.007
87
KnueselI.ChichaL.BritschgiM.SchobelS. A.BodmerM.HellingsJ. A.et al (2014). Maternal immune activation and abnormal brain development across CNS disorders.Nat. Rev. Neurol.10643–660. 10.1038/nrneurol.2014.187
88
KornT.KalliesA. (2017). T cell responses in the central nervous system.Nat. Rev. Immunol.17179–194. 10.1038/nri.2016.144
89
KrachtL.BorggreweM.EskandarS.BrouwerN.Chuva de Sousa LopesS. M.LamanJ. D.et al (2020). Human fetal microglia acquire homeostatic immune-sensing properties early in development.Science369530–537. 10.1126/science.aba5906
90
KrauerF.RiesenM.ReveizL.OladapoO. T.PorgoV.HaefligerA.et al (2017). Zika virus infection as a cause of congenital brain abnormalities and guillain – barre syndrome: systematic review.PLoS Med.14:e1002203. 10.1371/journal.pmed.1002203
91
KrennV.BosoneC.BurkardT. R.GarcezP. P.MirazimiA.KnoblichA.et al (2021). Organoid modeling of Zika and herpes simplex virus 1 infections reveals virus-specific responses leading to microcephaly.Cell Stem Cell281362–1379.e7. 10.1016/j.stem.2021.03.004
92
KumarA.HouS.AiroA. M.LimontaD.MancinelliV.BrantonW.et al (2016). Zika virus inhibits type-I interferon production and downstream signaling.EMBO Rep.171766–1775. 10.15252/embr.201642627
93
LazutkinA.PodgornyO.EnikolopovG. (2019). Modes of division and differentiation of neural stem cells.Behav. Brain Res.374:112118. 10.1016/j.bbr.2019.112118
94
LevitonA.AllredE. N.FichorovaR. N.KubanK. C. K.MichaelO.SheaT.et al (2016). Systemic inflammation on postnatal days 21 and 28 and indicators of brain dysfunction 2years later among children born before the 28th week of gestation.Early Hum. Dev.9325–32. 10.1016/j.earlhumdev.2015.11.004
95
LiG.NingZ.LiuY.LiX. (2017). Neurological manifestations of dengue infection.Front. Cell. Infect. Microbiol.7:449. 10.3389/fcimb.2017.00449
96
LiM.RansohoffR. M. (2008). Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology.Prog. Neurobiol.84116–131. 10.1016/j.pneurobio.2007.11.003
97
LiY.ZhangC.ChenX.YuJ.WangY.YangY.et al (2011). ICP34.5 protein of herpes simplex virus facilitates the initiation of protein translation by bridging eukaryotic initiation factor 2alpha (eIF2alpha) and protein phosphatase 1.J. Biol. Chem.28624785–24792. 10.1074/jbc.M111.232439
98
LiddelowS. A. (2015). Development of the choroid plexus and blood-CSF barrier.Front. Neurosci.9:32. 10.3389/fnins.2015.00032
99
LooY.-M.GaleM. (2011). Immune signaling by RIG-I-like receptors.Immunity34680–692. 10.1016/j.immuni.2011.05.003
100
LuB.JanL.JanY. N. (2000). Control of cell divisions in the nervous system: symmetry and asymmetry.Annu. Rev. Neurosci.23531–556. 10.1146/annurev.neuro.23.1.531
101
MagdalonJ.MansurF.Teles E SilvaA. L.de GoesV. A.ReinerO.SertiéA. L. (2020). Complement system in brain architecture and neurodevelopmental disorders.Front. Neurosci.14:23. 10.3389/fnins.2020.00023
102
MallardC.TremblayM.-E.VexlerZ. S. (2019). Microglia and neonatal brain injury.Neuroscience40568–76. 10.1016/j.neuroscience.2018.01.023
103
MednickS. A.MachonR. A.HuttunenM. O.BonettD. (1988). Adult schizophrenia following prenatal exposure to an influenza epidemic.Arch. Gen. Psychiatry45189–192. 10.1001/archpsyc.1988.01800260109013
104
MelchjorsenJ.SørensenL. N.PaludanS. R. (2003). Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function.J. Leukoc. Biol.74331–343. 10.1189/jlb.1102577
105
MeunierE.BrozP. (2016). Interferon-inducible GTPases in cell autonomous and innate immunity.Cell. Microbiol.18168–180. 10.1111/cmi.12546
106
MeyerU.FeldonJ.YeeB. K. (2009). A review of the fetal brain cytokine imbalance hypothesis of schizophrenia.Schizophr. Bull.35959–972. 10.1093/schbul/sbn022
107
MeyerU.NyffelerM.EnglerA.UrwylerA.SchedlowskiM.KnueselI.et al (2006). The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology.J. Neurosci.264752–4762. 10.1523/JNEUROSCI.0099-06.2006
108
MeyerU.YeeB. K.FeldonJ. (2007). The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse?Neuroscientist13241–256. 10.1177/1073858406296401
109
MillerR. J.RosteneW.ApartisE.BanisadrG.BiberK.MilliganE. D.et al (2008). Chemokine action in the nervous system.J. Neurosci.2811792–11795. 10.1523/JNEUROSCI.3588-08.2008
110
MiyamotoA.WakeH.IshikawaA. W.EtoK.ShibataK.MurakoshiH.et al (2016). Microglia contact induces synapse formation in developing somatosensory cortex.Nat. Commun.7:12540. 10.1038/ncomms12540
111
MosemanE. A.BlanchardA. C.NayakD.McGavernD. B. (2020). T cell engagement of cross-presenting microglia protects the brain from a nasal virus infection.Sci. Immunol.5:eabb1817. 10.1126/sciimmunol.abb1817
112
MousaA.SeigerA, KjaeldgaardA.BakhietM. (1999). Human first trimester forebrain cells express genes for inflammatory and anti-inflammatory cytokines.Cytokine1155–60. 10.1006/cyto.1998.0381
113
MunshiS.ParrilliV.RosenkranzJ. A. (2019). Peripheral anti-inflammatory cytokine Interleukin-10 treatment mitigates interleukin-1β–induced anxiety and sickness behaviors in adult male rats.Behav. Brain Res.372:112024. 10.1016/j.bbr.2019.112024
114
NadarajahB.ParnavelasJ. G. (2002). Modes of neuronal migration in the developing cerebral cortex.Nat. Rev. Neurosci.3423–432. 10.1038/nrn845
115
NairS.DiamondM. S. (2016). Innate immune interactions within the central nervous system modulate pathogenesis of viral infections.Curr. Opin. Immunol.3647–53. 10.1016/j.coi.2015.06.011
116
NayakD.RothT. L.McGavernD. B. (2014). Microglia development and function.Annu. Rev. Immunol.32367–402. 10.1146/annurev-immunol-032713-120240
117
NelsonL. H.LenzK. M. (2017). The immune system as a novel regulator of sex differences in brain and behavioral development.J. Neurosci. Res.95447–461. 10.1002/jnr.23821
118
OglesbeeM.NiewieskS. (2011). Measles virus neurovirulence and host immunity.Future Virol.685–99. 10.2217/fvl.10.70
119
OhkaS.NiheiC.YamazakiM.NomotoA. (2012). Poliovirus trafficking toward central nervous system via human poliovirus receptor-dependent and -independent pathway.Front. Microbiol.3:147. 10.3389/fmicb.2012.00147
120
O’KeefeG. M.NguyenV. T.BenvenisteE. N. (1999). Class II transactivator and class II MHC gene expression in microglia: modulation by the cytokines TGF-beta, IL-4, IL-13 and IL-10.Eur. J. Immunol.291275–1285. 10.1002/(SICI)1521-4141(199904)29:04<1275::AID-IMMU1275<3.0.CO;2-T
121
OkunE.GriffioenK. J.MattsonM. P. (2011). Toll-like receptor signaling in neural plasticity and disease.Trends Neurosci.34269–281. 10.1016/j.tins.2011.02.005
122
OppenheimR. W. (1991). Cell death during development of the nervous system.Annu. Rev. Neurosci.14453–501. 10.1146/annurev.ne.14.030191.002321
123
OzakiK.KatoD.IkegamiA.HashimotoA.SugioS.GuoZ.et al (2020). Maternal immune activation induces sustained changes in fetal microglia motility.Sci. Rep.10:21378. 10.1038/s41598-020-78294-2
124
PanT.PengZ.TanL.ZouF.ZhouN.LiuB.et al (2018). Nonsteroidal anti-inflammatory drugs potently inhibit the replication of zika viruses by inducing the degradation of AXL.J. Virol.92:e01018-18. 10.1128/JVI.01018-18
125
PandeyM.ChauhanM.AwasthiS. (2017). Interplay of cytokines in preterm birth.Indian J. Med. Res.146316–327. 10.4103/ijmr.IJMR_1624_14
126
PaolicelliR. C.BolascoG.PaganiF.MaggiL.ScianniM.PanzanelliP.et al (2011). Synaptic pruning by microglia is necessary for normal brain development.Science (New York, N.Y.)3331456–1458. 10.1126/science.1202529
127
PardridgeW. M. (2005). Molecular biology of the blood-brain barrier.Mol. Biotechnol.3057–70.
128
PawelecP.Ziemka-NaleczM.SypeckaJ.ZalewskaT. (2020). The impact of the CX3CL1/CX3CR1 axis in neurological disorders.Cells9:2277. 10.3390/cells9102277
129
PellegriniL.AlbeckaA.MalleryD. L.KellnerM. J.PaulD.CarterA. P.et al (2020). SARS-CoV-2 infects the brain choroid plexus and disrupts the blood-CSF barrier in human brain organoids.Cell Stem Cell27951–961.e5. 10.1016/j.stem.2020.10.001
130
PerryV. H.NicollJ. A. R.HolmesC. (2010). Microglia in neurodegenerative disease.Nat. Rev. Neurol.6193–201. 10.1038/nrneurol.2010.17
131
PetersonS. E.YangA. H.BushmanD. M.WestraJ. W.YungY. C.BarralS.et al (2012). Aneuploid cells are differentially susceptible to caspase-mediated death during embryonic cerebral cortical development.J. Neurosci.3216213–16222. 10.1523/JNEUROSCI.3706-12.2012
132
PiersonT. C.DiamondM. S. (2020). The continued threat of emerging flaviviruses.Nat. Microbiol.5796–812. 10.1038/s41564-020-0714-0
133
PrinzM.JungS.PrillerJ. (2019). Microglia biology: one century of evolving concepts.Cell179292–311. 10.1016/j.cell.2019.08.053
134
Puerta-GuardoH.GlasnerD. R.HarrisE. (2016). Dengue virus NS1 disrupts the endothelial glycocalyx, leading to hyperpermeability.PLoS Pathog.12:e1005738. 10.1371/journal.ppat.1005738
135
RadjaviA.SmirnovI.KipnisJ. (2014). Brain antigen-reactive CD4+ T cells are sufficient to support learning behavior in mice with limited T cell repertoire.Brain Behav. Immun.3558–63. 10.1016/j.bbi.2013.08.013
136
RatnayakeU.QuinnT.WalkerD. W.DickinsonH. (2013). Cytokines and the neurodevelopmental basis of mental illness.Front. Neurosci.7:180. 10.3389/fnins.2013.00180
137
RavalA.PuriN.RathP. C.SaxenaR. K. (1998). Cytokine regulation of expression of class I MHC antigens cytokines which modulate expression of MHC class I molecules.Exp. Mol. Med.301–13.
138
RedzicZ. (2011). Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences.Fluids Barriers CNS8:3. 10.1186/2045-8118-8-3
139
RehenS. K.McConnellM. J.KaushalD.KingsburyM. A.YangA. H.ChunJ. (2001). Chromosomal variation in neurons of the developing and adult mammalian nervous system.Proc. Natl. Acad. Sci. U.S.A.9813361–13366. 10.1073/pnas.231487398
140
RobertsL. M.BlackD. S.RamanC.WoodfordK.ZhouM.HaggertyJ. E.et al (2008). Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation.Neuroscience155423–438. 10.1016/j.neuroscience.2008.06.015
141
RosenblatJ. D. (2019). Targeting the immune system in the treatment of bipolar disorder.Psychopharmacology2362909–2921. 10.1007/s00213-019-5175-x
142
RudolphM. D.GrahamA. M.FeczkoE.Miranda-DominguezO.RasmussenJ. M.NardosR.et al (2018). Maternal IL-6 during pregnancy can be estimated from newborn brain connectivity and predicts future working memory in offspring.Nat. Neurosci.21765–772. 10.1038/s41593-018-0128-y
143
SanjabiS.ZenewiczL. A.KamanakaM.FlavellR. A. (2009). Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity.Curr. Opin. Pharmacol.9447–453. 10.1016/j.coph.2009.04.008
144
SaundersN. R.LiddelowS. A.DziegielewskaK. M. (2012). Barrier mechanisms in the developing brain.Front. Pharmacol.3:46. 10.3389/fphar.2012.00046
145
ScolaG.DuongA. (2017). Prenatal maternal immune activation and brain development with relevance to psychiatric disorders.Neuroscience346403–408. 10.1016/j.neuroscience.2017.01.033
146
SezginE.JabsD. A.HendricksonS. L.Van NattaM.ZdanovA.LewisA.et al (2010). Effect of host genetics on the development of cytomegalovirus retinitis in patients with AIDS.J. Infect. Dis.202606–613. 10.1086/654814
147
ShresthaB.ZhangB.PurthaW. E.KleinR. S.DiamondM. S. (2008). Tumor necrosis factor alpha protects against lethal West Nile virus infection by promoting trafficking of mononuclear leukocytes into the central nervous system.J. Virol.828956–8964. 10.1128/JVI.01118-08
148
SicotteN. L.VoskuhlR. R. (2001). Onset of multiple sclerosis associated with anti-TNF therapy.Neurology571885–1888. 10.1212/wnl.57.10.1885
149
SierraA.EncinasJ. M.DeuderoJ. J. P.ChanceyJ. H.EnikolopovG.Overstreet-WadicheL. S.et al (2010). Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis.Cell Stem Cell7483–495. 10.1016/j.stem.2010.08.014
150
SilvermanM. N.PearceB. D.BironC. A.MillerA. H. (2005). Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection.Viral Immunol.1841–78. 10.1089/vim.2005.18.41
151
SmithS. A.KotwalG. J. (2001). Virokines: novel immunomodulatory agents.Expert Opin. Biol. Ther.1343–357. 10.1517/14712598.1.3.343
152
SmithS. E. P.LiJ.GarbettK.MirnicsK.PattersonP. H. (2007). Maternal immune activation alters fetal brain development through interleukin-6.J. Neurosci.2710695–10702. 10.1523/JNEUROSCI.2178-07.2007
153
SolekC. M.FarooqiN.VerlyM.LimT. K.RuthazerE. S. (2018). Maternal immune activation in neurodevelopmental disorders.Dev. Dyn.247588–619. 10.1002/dvdy.24612
154
SroykhamW.WongsawatY. (2019). Effects of brain activity, morning salivary cortisol, and emotion regulation on cognitive impairment in elderly people.Medicine98:e16114. 10.1097/MD.0000000000016114
155
StassartR. M.MöbiusW.NaveK.-A.EdgarJ. M. (2018). The axon-myelin unit in development and degenerative disease.Front. Neurosci.12:467. 10.3389/fnins.2018.00467
156
SternH.BoothJ. C.ElekS. D.FleckD. G. (1969). Microbial causes of mental retardation. The role of prenatal infections with cytomegalovirus, rubella virus, and toxoplasma.Lancet2443–448. 10.1016/s0140-6736(69)90162-7
157
StevensB.AllenN. J.VazquezL. E.HowellG. R.ChristophersonK. S.NouriN.et al (2007). The classical complement cascade mediates CNS synapse elimination.Cell1311164–1178. 10.1016/j.cell.2007.10.036
158
StilesJ.JerniganT. L. (2010). The basics of brain development.Neuropsychol. Rev.20327–348. 10.1007/s11065-010-9148-4
159
StoermerK. A.MorrisonT. E. (2011). Complement and viral pathogenesis.Virology411362–373. 10.1016/j.virol.2010.12.045
160
StolpH. B. (2013). Neuropoietic cytokines in normal brain development and neurodevelopmental disorders.Mol. Cell. Neurosci.5363–68. 10.1016/j.mcn.2012.08.009
161
StrafaceG.SelminA.ZanardoV.De SantisM.ErcoliA.ScambiaG. (2012). Herpes simplex virus infection in pregnancy.Infect. Dis. Obstet. Gynecol.2012:385697. 10.1155/2012/385697
162
SubramanianL.BershteynM.ParedesM. F.KriegsteinA. R. (2017). Dynamic behaviour of human neuroepithelial cells in the developing forebrain.Nat. Commun.8:14167. 10.1038/ncomms14167
163
SuiY.Stehno-BittelL.LiS.LoganathanR.DhillonN. K.PinsonD.et al (2006). CXCL10-induced cell death in neurons: role of calcium dysregulation.Eur. J. Neurosci.23957–964. 10.1111/j.1460-9568.2006.04631.x
164
TanabeS.YamashitaT. (2018). B-1a lymphocytes promote oligodendrogenesis during brain development.Nat. Neurosci.21506–516. 10.1038/s41593-018-0106-4
165
TanakaT.NarazakiM.KishimotoT. (2014). IL-6 in inflammation, immunity, and disease.Cold Spring Harb. Perspect. Biol.6:a016295. 10.1101/cshperspect.a016295
166
TauG. Z.PetersonB. S. (2010). Normal development of brain circuits.Neuropsychopharmacology.35147–168. 10.1038/npp.2009.115
167
TraiffortE.KassoussiA.ZahafA.LaouaremY. (2020). Astrocytes and microglia as major players of myelin production in normal and pathological conditions.Front. Cell. Neurosci.14:79. 10.3389/fncel.2020.00079
168
TrettelF.Di CastroM. A.LimatolaC. (2020). Chemokines: key molecules that orchestrate communication among neurons, microglia and astrocytes to preserve brain function.Neuroscience439230–240. 10.1016/j.neuroscience.2019.07.035
169
Van RieA.MupualaA.DowA. (2008). Impact of the HIV/AIDS epidemic on the neurodevelopment of preschool-aged children in Kinshasa, Democratic Republic of the Congo.Pediatrics122e123–e128. 10.1542/peds.2007-2558
170
Van SantC.HagglundR.LopezP.RoizmanB. (2001). The infected cell protein 0 of herpes simplex virus 1 dynamically interacts with proteasomes, binds and activates the cdc34 E2 ubiquitin-conjugating enzyme, and possesses in vitro E3 ubiquitin ligase activity.Proc. Natl. Acad. Sci. U.S.A.988815–8820. 10.1073/pnas.161283098
171
VermaS.LoY.ChapagainM.LumS.KumarM.GurjavU.et al (2009). West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: transmigration across the in vitro blood-brain barrier.Virology385425–433. 10.1016/j.virol.2008.11.047
172
WatkinsL. R.MaierS. F.GoehlerL. E. (1995). Cytokine-to-brain communication: a review & analysis of alternative mechanisms.Life Sci.571011–1026. 10.1016/0024-3205(95)02047-m
173
WeiH.AlbertsI.LiX. (2014). The apoptotic perspective of autism.Int. J. Dev. Neurosci.3613–18. 10.1016/j.ijdevneu.2014.04.004
174
WerlingD. M. (2016). The role of sex-differential biology in risk for autism spectrum disorder.Biol. Sex Differ.7:58. 10.1186/s13293-016-0112-8
175
WerlingD. M.GeschwindD. H. (2013). Sex differences in autism spectrum disorders.Curr. Opin. Neurol.26146–153. 10.1097/WCO.0b013e32835ee548
176
WuW.DietzeK. K.GibbertK.LangK. S.TrillingM.YanH.et al (2015). TLR ligand induced IL-6 counter-regulates the anti-viral CD8(+) T cell response during an acute retrovirus infection.Sci. Rep.5:10501. 10.1038/srep10501
177
XuN.LiX.ZhongY. (2015). Inflammatory cytokines: potential biomarkers of immunologic dysfunction in autism spectrum disorders.Mediators Inflamm.2015:531518. 10.1155/2015/531518
178
YamaguchiY.MiuraM. (2015). Programmed cell death in neurodevelopment.Dev. Cell32478–490. 10.1016/j.devcel.2015.01.019
179
YamaguchiY.ShinotsukaN.NonomuraK.TakemotoK.KuidaK.YosidaH.et al (2011). Live imaging of apoptosis in a novel transgenic mouse highlights its role in neural tube closure.J. Cell Biol.1951047–1060. 10.1083/jcb.201104057
180
ZagerA.PinheiroM. L.Ferraz-de-PaulaV.RibeiroA.Palermo-NetoJ. (2013). Increased cell-mediated immunity in male mice offspring exposed to maternal immune activation during late gestation.Int. Immunopharmacol.17633–637. 10.1016/j.intimp.2013.08.007
181
ZaninN.Viaris de LesegnoC.LamazeC.BlouinC. M. (2021). Interferon receptor trafficking and signaling: journey to the cross roads.Front. Immunol.11:3512. 10.3389/fimmu.2020.615603
182
ZengelerK. E.LukensJ. R. (2021). Innate immunity at the crossroads of healthy brain maturation and neurodevelopmental disorders.Nat. Rev. Immunol.21454–468. 10.1038/s41577-020-00487-7
183
ZhuH.CongJ.YuD.BresnahanW. A.ShenkT. E. (2001). Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication.Proc. Natl. Acad. Sci. U.S.A.993932–3937.
Summary
Keywords
autism spectrum disorder (ASD), blood brain Barrier (BBB), blood CSF barrier (BCSFB), microcephaly, neurodevelopment, inflammation, cytokines
Citation
Ganguli S and Chavali PL (2021) Intrauterine Viral Infections: Impact of Inflammation on Fetal Neurodevelopment. Front. Neurosci. 15:771557. doi: 10.3389/fnins.2021.771557
Received
06 September 2021
Accepted
18 October 2021
Published
10 November 2021
Volume
15 - 2021
Edited by
Yasir Ahmed Syed, Cardiff University, United Kingdom
Reviewed by
Sara A. Abdulla, Qatar Biomedical Research Institute, Qatar; Sarah Mulkey, Children’s National Hospital, United States
Updates
Copyright
© 2021 Ganguli and Chavali.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Pavithra L. Chavali, plchavali@ccmb.res.in
This article was submitted to Neurodevelopment, a section of the journal Frontiers in Neuroscience
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.